ANRO
Price
$2.35
Change
+$0.07 (+3.07%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
61.72M
25 days until earnings call
XTLB
Price
$1.46
Change
+$0.16 (+12.31%)
Updated
Apr 25, 04:50 PM (EDT)
Capitalization
10.95M
Ad is loading...

ANRO vs XTLB

Header iconANRO vs XTLB Comparison
Open Charts ANRO vs XTLBBanner chart's image
Alto Neuroscience
Price$2.35
Change+$0.07 (+3.07%)
Volume$2.3K
Capitalization61.72M
XTL Biopharmaceuticals
Price$1.46
Change+$0.16 (+12.31%)
Volume$125
Capitalization10.95M
ANRO vs XTLB Comparison Chart
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. XTLB commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and XTLB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (ANRO: $2.28 vs. XTLB: $1.30)
Brand notoriety: ANRO and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 28% vs. XTLB: 14%
Market capitalization -- ANRO: $61.72M vs. XTLB: $10.95M
ANRO [@Biotechnology] is valued at $61.72M. XTLB’s [@Biotechnology] market capitalization is $10.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, ANRO is a better buy in the long-term than XTLB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish.

  • ANRO’s TA Score: 4 bullish, 3 bearish.

Price Growth

ANRO (@Biotechnology) experienced а +0.88% price change this week, while XTLB (@Biotechnology) price change was +15.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

ANRO is expected to report earnings on May 20, 2025.

XTLB is expected to report earnings on Dec 03, 2024.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANRO($61.7M) has a higher market cap than XTLB($11M). XTLB YTD gains are higher at: -35.828 vs. ANRO (-46.099). XTLB has higher annual earnings (EBITDA): 630K vs. ANRO (-55.61M). ANRO has more cash in the bank: 182M vs. XTLB (133K). ANRO (0) and XTLB (0) have equivalent revenues.
ANROXTLBANRO / XTLB
Capitalization61.7M11M561%
EBITDA-55.61M630K-8,826%
Gain YTD-46.099-35.828129%
P/E RatioN/AN/A-
Revenue00-
Total Cash182M133K136,842%
Total Debt16.8MN/A-
FUNDAMENTALS RATINGS
XTLB: Fundamental Ratings
XTLB
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANRO
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITIX31.85N/A
N/A
MFS Massachusetts Investors Tr I
CBSYX15.27N/A
N/A
AB Global Risk Allocation Adv
ATEYX143.74N/A
N/A
AB Sustainable Global Thematic Advisor
MSGZX13.98N/A
N/A
MassMutual Small Cap Gr Eq I
VSQYX15.42N/A
N/A
Invesco MSCI World SRI Index Y

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+0.44%
NUVL - ANRO
27%
Poorly correlated
+1.75%
XTLB - ANRO
27%
Poorly correlated
+7.00%
GUTS - ANRO
26%
Poorly correlated
-3.76%
PRME - ANRO
25%
Poorly correlated
-1.69%
BIVI - ANRO
24%
Poorly correlated
+6.42%
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been loosely correlated with SER. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XTLB jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
+7.00%
SER - XTLB
59%
Loosely correlated
+5.36%
BCLI - XTLB
27%
Poorly correlated
+5.75%
ADTX - XTLB
27%
Poorly correlated
-0.43%
ANRO - XTLB
27%
Poorly correlated
+0.44%
BCRX - XTLB
25%
Poorly correlated
+3.27%
More